Natco To Launch Generic Vidaza In US Market Soon

Hyderabad: Natco Pharma Limited on Tuesday said it got the final approval of Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (FDA) for the generic version of Vidaza (Azacitidine for Injection, 100mg per Vial), single-Dose Vial. According to a statement issued by the drug maker, Natco and its marketing partner Breckenridge Pharmaceutical, Inc. (BPI) plan to launch this product in the USA market in the...